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SUMMARY
1. Duchenne muscular dystrophy (DMD), a severe muscle
wasting disease of young boys with an incidence of one in every
3000, results from a mutation in the gene that encodes dystrophin.
The absence of dystrophin expression in skeletal muscles
and heart results in the degeneration of muscle fibres and,
consequently, severe muscle weakness and wasting. The mdx
mouse discovered in 1984, with some adjustments for differences,
has proven to be an invaluable model for scientific investigations
of dystrophy.
2. The development of the diaphagm strip preparation
provided an ideal experimental model for investigations of
skeletal muscle impairments in structure and function induced
by interactions of disease- and age-related factors. Unlike the
limb muscles of the mdx mouse, which show adaptive changes
in structure and function, the diaphragm strip preparation
reflects accurately the deterioration in muscle structure and
function observed in boys with DMD.
3. The advent of sophisticated servo motors and force
transducers interfaced with state-of-the-art software packages
to drive complex experimental designs during the 1990s greatly
enhanced the capability of the mdx mouse and the diaphragm
strip preparation to evaluate more accurately the impact of the
disease on the structure–function relationships throughout the
life span of the mouse.
4. Finally, during the 1990s and through the early years of the
21st century, many promising, sophisticated genetic techniques
have been designed to ameliorate the devastating impact of
muscular dystrophy on the structure and function of skeletal
muscles. During this period of rapid development of promising
genetic therapies, the combination of the mdx mouse and the
diaphragm strip preparation has provided an ideal model for the
evaluation of the success, or failure, of these genetic techniques
to improve dystrophic muscle structure, function or both. With
the 2 year life span of the mdx mouse, the impact of age-related
effects can be studied in this model.
Key words: contractility, contraction-induced injury, Duchenne
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THE mdx MOUSE AS A MODEL FOR DUCHENNE 
MUSCULAR DYSTROPHY
In Duchenne muscular dystrophy (DMD), a mutation in the gene
that encodes dystrophin results in the absence of dystrophin expres-
sion. Dystrophin and the dystrophin–glycoprotein complex (DGC)
appear to link the costomeric structures of the cytoskeleton to the
basement membrane of muscle fibres.1,2 The exact linkage of the
basement membrane adjacent to the z-lines to collagen-1 and
collagen-3 in the extracellular matrix (ECM) is unknown. Lack of
dystrophin expression in muscle fibres leads to a progressive weakness
and wasting of skeletal muscles of boys with DMD that results in
confinement to wheelchairs by approximately 12 years of age and
most boys have died by their mid-20s owing to respiratory or cardiac
failure.3 The mdx mouse discovered by Bulfield et al. in 19844 lacks
dystrophin expression in muscle and consequently provides an
effective small animal model for studies of the effects of the lack
of dystrophin on skeletal muscle structure and function throughout
the life span of the mouse.5 The mdx mouse has also provided a
model for the impact of the lack of dystrophin on the length of the
life of the mouse,6 on the structure and function of different skeletal
muscles of the limbs,7 on limb skeletal muscles throughout the life
span,5 on the susceptibility to contraction-induced injury8–14 and on
the efficacy of a variety of implantation15 and genetic studies to
reverse the dystrophic symptoms.16–19
The mdx mouse does have some short-comings as a model for
investigations of the development of structural and functional defi-
ciencies in skeletal muscles caused by the absence of dystrophin
expression. The major deficiency of the model is that adaptations
occur in limb muscles of mdx mice and these adaptations result in
hypertrophy of the skeletal muscles of the limbs.5 The hypertrophy
produces a substantial increase in muscle mass that maintains
maximum isometric force but, owing to the presence of damaged
fibres, results in an approximate 20% loss in maximum specific
Correspondence: John A Faulkner, 2035 Biomedical Science Research
Building, 109 Zina Pitcher Place, Ann Arbor, MI 48109-2200, USA. Email:
jafaulk@umich.edu
AuPS Plenary Lecture, Combio2006, Brisbane, September 2006. This
paper was peer reviewed under the supervision of the AuPS Editor. The paper
is being published with the permission of AuPS and was initially published
on the AuPS website http://www.aups.org.au
Received 3 May 2007; revision 12 October 2007; accepted 12 November
2007.
726 JA Faulkner et al.
force.5,7 Interestingly, the diaphragm muscle does not undergo such
an adaptation. Consequently, the diaphragm muscle of the mdx
mouse more accurately reflects the degenerative changes observed
in both limb and diaphragm muscles of boys with DMD.7,12,13,19–24
Because of the more accurate representation of the degenerative
changes, we have used the diaphragm strip preparation to investigate
the progression of muscle weakness and muscle wasting throughout
the life span of the mdx mouse, as well as the effect of various genetic
therapeutic interventions. The comparisons among mdx, wild-type
(WT) and transgenic mice include the capacity for the development
of maximum specific force, normalized power and the susceptibility
to injury when subjected to protocols of lengthening contractions.
DIAPHRAGM STRIP PREPARATION OF THE 
mdx MOUSE
Our laboratory has had a long and sustained interest in the structure
and function of the diaphragm muscle.25,26 In 1954, Ritchie27 first
described the diaphragm strip preparation of the rat. The diaphragm
strip provided an immediate, novel and innovative approach to the
function of the diaphragm.7,12,13,23,27 The rat was anaesthetized by an
appropriate anaesthetic, administered as required to keep the rat
unresponsive to tactile stimuli. The surgical procedure then consisted
of excising the total diaphragm muscle from the anaesthetized rat
and immersing the diaphragm muscle, with rib attachments and
central tendon intact, in an oxygenated bath of physiological saline.
A small strip of intact muscle fibres approximately 5 mm wide was
then dissected carefully from the central tendon to the attachment
of the fibres on a single rib. The diaphragm strip was then attached
to a servo motor and a force transducer and measurements of force
were made during shortening, isometric and lengthening contractions.23
Such a diaphragm strip preparation obtained from mdx mice could
be used for investigations of the effects of the lack of dystrophin on
the mechanical properties, maximum specific force, maximum
normalized power and susceptibility to injury during lengthening
contractions or of the effectiveness of various gene therapies in
reversing the dystrophic symptoms.16,18–20,28 Such studies with the
diaphragm strip preparation have demonstrated the relative effectiveness
of restoring various highly functional-length16 or mini-dystrophin
fusion genes for cell and gene therapy of DMD.18–20,23
DIAPHRAGM STRIP PREPARATION DURING 
AGEING OF mdx MICE
Dupont-Versteegen and McCarter7 provided an early, insightful
comparison of the age-related changes up to 20 months of age for
the maximum specific forces of diaphragm strips, soleus muscles
and extensor digitorum longus (EDL) muscles of mdx and WT
mice.7 The soleus and EDL muscles of mdx and WT mice showed
rapid increases in specific force up to 4 months of age, with a plateau
at approximately 205 and 245 kN/m2 for mdx and WT mice, respectively.7
For both mdx and WT mice, the plateau in force extended to 20
months of age. Unfortunately, the values for specific forces for
diaphragm strips of WT mice varied so greatly, with a range of 160–
300 kN/m2 compared with a normal range of 210–270 kN/m2,19,23
that age-related changes were not discernable even for WT mice.
Despite the considerable variability among the specific forces of the
diaphragm strips of both the mdx and WT mice in the Dupont-
Versteegen and McCarter study,7 the values for the specific forces
of the two groups showed no overlap at any age, providing strong
evidence of a deficit for mdx mice.
Our data on diaphragm strips now extend from sampling points
between 14 days and 24 months of age.5,7,16,22 The time point of 24
months of age is within a few months of the maximum life span (28
months) of mdx mice, compared with a life span of 36 months for
WT mice.6 For both young and old WT mice, histological sections
of diaphragm strips show tightly packed viable fibres.23 Con-
sequently, the specific forces and normalized power are simply
divided by the total cross-sectional area (CSA) of the diaphragm
strip. Throughout the life span of the WT mice, values for the
diaphragm strips range from 240 to 250 kN/m2 for maximum
specific forces and from 54 to 55 W/kg2 for maximum normalized
power; these values are in excellent agreement with each other and
with control values for limb muscles of WT mice.29,30 In contrast
with WT mice with 100% of the CSA composed of viable muscle
fibres, only 70% of the CSA of the diaphragm strips of young mdx
mice was composed of viable fibres and, for the old mdx mice, the
percentage of the CSA composed of viable fibres had decreased to
41%.23 Even with corrections for the damaged and necrotic fibres,
the diaphragm strip preparations of mdx mice at 3 months of age
had specific forces only 62% of the value for WT mice and, at 24
months, only 48% of values for WT mice (Fig. 1). Similarly, with
the same corrections for volume, the normalized power of the
diaphragm strips of young mdx mice was 45% that of the WT mice,
whereas that of old mdx mice was only 30% (Fig. 2).
Although age-related changes in specific force have been
investigated in limb muscles of mdx mice,5,7 the limb muscles of mdx
mice adapt to ongoing damage to fibres with a 20–30% hypertrophy.5,7
In contrast, the diaphragm muscle of the mdx mouse does not appear
to undergo such an adaptation and, consequently, the diaphragm strip
has been extremely useful in following the age-related changes that
Fig. 1 Comparisons of the maximum specific forces of diaphragm strips
obtained from mdx and wild-type (WT) mice at 3, 5, 17 (WT mice only)
and 24 months of age. Maximum isometric forces were normalized to
specific force by dividing the force developed by diaphragm strips of the WT
mice by the total cross-sectional area (CSA) of the diaphragm strips and for
the mdx mice by dividing the maximum force by the total area of viable fibres
in the diaphragm strip (dashed lines) or by the total CSA of the diaphragm
strip including the damaged and ‘ghost’ fibres (dotted lines; see text for
definition). (), WT mice (data from Lynch et al.23); (), mdx mice (data
from Lynch et al.23); (), WT mice (data from Cox et al.23); (), mdx mice
(data from Cox et al.23); (), mdx mice (uncorrected for damaged fibres).
Diaphragm strips in gene therapy 727
occur in skeletal muscles of mdx mice unimpeded by any adaptive
changes.5,7,22 Our data for the specific forces of the diaphragm strips
for both mdx and WT mice indicate a clear age-related decline in
specific force for diaphragm strips normalized for viable fibre CSA
and even more steeply for specific forces normalized for total CSA
of the diaphragm strips. For WT mice, the EDL and soleus muscles
display a loss of approximately 30% in maximum specific force and
maximum normalized power by 28 months of age29,30 and presumably
the diaphragm strips from diaphragm muscles of WT mice would
show a similar deficit. Certainly, respiratory function of elderly
humans is decreased considerably.3 For mdx mice, similar deficits
in structure and function of the diaphragm muscles undoubtedly
occur, but at an even earlier age than for the WT mice. For mdx mice,
the average life span (50% of the cohort deceased) is 22 months and
the maximum life span is 28 months (cf. 27 and 36 months, respectively,
for WT mice).6 Consequently, with a linear decline in specific force
and normalized power of the diaphragm muscle of mdx mice
throughout their life span, the specific force and normalized power
of the total diaphragm strips, not corrected for damaged fibres, are
19 and 10%, respectively, of values for WT mice. These values place
the mdx mice at considerable risk of respiratory failure. Consequently,
the citing of respiratory failure and heart failure as the major causes
of the shortened life-span of mdx mice is not surprising.6
DIAPHRAGM STRIP PREPARATION OF THE 
mdx MOUSE IN ASSESSMENTS OF CELL AND 
GENE THERAPY
Based on the difficulties that arose through our comparisons of data
on the specific forces measured on diaphragm strips of mdx and WT
mice by different laboratories (see above), the decision was made
to restrict the assessments of cell and gene therapy to data obtained
through collaborations between the Chamberlain laboratory
performing interventions using cell and gene therapy techniques
and the Faulkner laboratory performing assessments of muscle
contractility.16,18–20,28
Beginning with the original elimination of the dystrophic
symptoms in the mdx mouse by the overexpression of dystrophin in
transgenic mdx mice,16 the diaphragm strip preparation has provided
a highly valuable muscle preparation for the evaluation of a wide
variety of gene therapies for the treatment of muscular dystrophy in
the mdx mouse.12,13,17–21,28 In 3-month-old mdx mice overexpressing
dystrophin, the specific forces (Fig. 3) and normalized powers of the
diaphragm strip were not different from those of WT mice of
comparable age.16 In 1994, Rafael et al.28 demonstrated that expres-
sion of a truncated dystrophin mini-gene that was missing exons
71–74 similarly eliminated the dystrophic pathology in both the
structure and function (Fig. 3) of the diaphragm strip. Dystrophin
is a multidomain protein that links the actin cytoskeleton through
the DGC to laminin in the ECM.31 Crawford et al.20 demonstrated
that transgenic mouse lines with deletions throughout the entire
COOH-terminal domain assembled the DGC successfully and had
WT values for muscle structure and function (Fig. 3) in both limb
muscles and diaphragm strip. Subsequently, Harper et al.18 described
detailed studies aimed at overcoming complications in attempts to
develop gene therapy for DMD caused by the enormous size of the
dystrophin gene. After a detailed functional analysis of the structural
domains of the dystrophin protein, Harper et al. concluded that multiple
regions of the protein could be deleted in various combinations that
Fig. 2 Histograms showing maximum normalized power developed by
diaphragm strips obtained from diaphragm muscles of wild-type (WT) and
mdx mice. The maximum power developed by the diaphragm strips of mdx
and WT mice was normalized by the mass of the total diaphragm strip for
the WT mice, for the mass of the viable fibres in the diaphragm strips of the
mdx mice and by the total mass of the diaphragm strip (including the mass
of the damaged and even ‘ghost’ (see text for definition) fibres) for mdx mice.
*P £ 0.001 compared with WT mice; †P £ 0.001 compared with mdx
(corrected) mice. (), WT mice (data from Lynch et al.23); (), mdx mice
corrected for damaged fibres (data from Lynch et al.23); ( ), mdx mice
uncorrected for damaged fibres.
Fig. 3 Histograms showing the specific force developed by diaphragm
strips obtained from diaphragm muscles of wild-type (WT; ) and mdx ()
mice, as well as mdx mice treated with various genetic therapies ( ). In
transgenic mdx mice that were 3 months of age, Cox et al.16 overexpressed
dystropin; in mice that were 4 months of age, Rafael et al.28 expressed a
truncated mini-gene; in mice that were 6 month of age, Crawford et al.20
deleted the entire COOH-terminal domain of the dystrophin molecule;
Harper et al.18 deleted multiple regions of dystrophin in a variety of different
combinations in mice that were 3 months of age; and, Li et al.19 engineered
a miniDys-GFP gene that removed much of the central rod domain of the
dystrophin in mice that were 7–10 months of age. With each of these cell
and gene therapy interventions, the specific forces of the diaphragm strips
returned to values not different from those of the WT mice. *P £ 0.001
compared with WT mice.
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generated highly functional mini- and microdystrophins. Diaphragm
muscles that expressed even the smallest dystrophins had greater
specific forces (Fig. 3) than dystrophic mdx muscles. Power was not
measured, but presumably would have been similarly improved.
The autologous transplantation of myogenic stem cells transduced
with a therapeutic expression cassette also offers a highly promising
technique for the treatment of DMD.19 Despite the promise of this
technique, the development of this method has been hampered by a
number of critical difficulties that include: (i) the very low frequency
rates for the engraftment of cells; (ii) the tracing of specific cells
that have been transplanted; (iii) the inability to halt muscle necrosis
due to the rapid loss of autologous cells carrying marker genes; and
(iv) the inefficient transfer of a large dystrophin gene into myogenic
stem cells.19
To avoid these difficulties, a 5.7 kb miniDystrophin-GFP fusion
gene was engineered.19 The miniDystrophin-GFP fusion gene
replaced the dystrophin COOH-terminal domain with an enhanced
green fluorescent protein (eGFP) coding sequence after the removal
of much of the dystrophin central rod domain. A transgenic mdx4cv
mouse expressed the miniDys fusion protein under the control of a
skeletal muscle-specific promoter. The green fusion protein was
localized on the sarcolemma of muscle fibres and resulted in the
assembly of the DGC. For the diaphragm strip, compared with
age-matched WT mice, the mdx4cv mice showed a 50% decrease in
specific force.19 In contrast, the specific forces for the diaphragm
strip obtained from the transgenic mdx4cv mice and those from WT
mice were not different. Furthermore, after the lengthening contraction
protocol, the force deficit of the diaphragm strip of the mdx4cv mice
was almost threefold greater than that of WT mice, whereas that of
the transgenic mdx4cv mice was not different (Fig. 4).
For WT mice, the phenomenon of contraction-induced injury to
muscle fibres results only during ‘lengthening contractions’,32 when
muscles are stretched during a maximum, or near-maximum
contraction. In contrast, muscles of mdx mice may also be injured
by isometric contractions (DR Claflin and SV Brooks, unpubl. data,
2007). The most useful measure of the susceptibility to injury of
fibres, or whole muscles, is the force deficit (the decrease in isometric
force developed after an injury producing protocol of lengthening
contractions expressed as a percentage of the initial isometric force
developed by the uninjured muscle prior to the procedure). The fibres
in skeletal muscles of young WT mice are highly resistant to injury,33
whereas those of old WT mice are much more easily injured.34,35 The
fibres in dystrophic muscles are extremely sensitive to contraction-
induced injury (Fig. 4). Protocols of lengthening contractions that
cause only slight injuries, with force deficits of 10% for EDL
muscles and 14% for diaphragm strips of young WT mice, cause
severe injury to dystrophic muscles with force deficits of 75% for
EDL muscles and 40% for diaphragm strips.19 Consequently, the
measurement of the sensitivity of skeletal muscles to contraction-
induced injury produced by protocols of lengthening contractions
provides a powerful tool to assess the efficacy of gene therapy, as
evidenced by no difference between the force deficits for the
diaphragm strip obtained from the transgenic mdx4cv mice and that
of WT mice (Fig. 4).
We conclude that diaphragm strips dissected from the diaphragm
muscles of young and old WT, mdx and transgenic mdx mice provide
an extremely useful preparation for the evaluation of age-related
changes in skeletal muscle structure and function and on the efficacy
of a wide range of genetic manipulations and interventions. Com-
pared with limb muscles, the diaphragm strip has the advantage of
assessing a comparable deficit in specific force and normalized
power and a magnitude of contraction-induced injury comparable
to the magnitude of the disturbances observed in the human expression
of the disease. As such, the interpretation of the success or failure
of an intervention is much more clearly defined.
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